A suitable time point for quantifying the radiochemical purity of <sup>225</sup>Ac-labeled radiopharmaceuticals.

Kelly, James M; Amor-Coarasa, Alejandro; Sweeney, Elizabeth; Wilson, Justin J; Causey, Patrick W; Babich, John W

A suitable time point for quantifying the radiochemical purity of ²²⁵Ac-labeled radiopharmaceuticals.

Kelly, James M; Amor-Coarasa, Alejandro; Sweeney, Elizabeth; Wilson, Justin J; Causey, Patrick W; Babich, John W.

Afiliación

Kelly JM; Department of Radiology, Molecular Imaging Innovations Institute (MI3), Weill Cornell Medicine, New York, NY, 10065, USA.
Amor-Coarasa A; Department of Radiology, Albert Einstein College of Medicine, Bronx, NY, 10461, USA.
Sweeney E; Division of Biostatistics, Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, 10065, USA.
Wilson JJ; Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY, 14853, USA.
Causey PW; Canadian Nuclear Laboratories, Chalk River, ON, K0J 1J0, Canada.
Babich JW; Department of Radiology, Molecular Imaging Innovations Institute (MI3), Weill Cornell Medicine, New York, NY, 10065, USA. jwbabich@gmail.com.

EJNMMI Radiopharm Chem ; 6(1): 38, 2021 Dec 20.

Article en En | MEDLINE | ID: mdl-34928478

Palabras clave

Ac-225; Quality control; Radiopharmacy; Targeted alpha therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: EJNMMI Radiopharm Chem Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google